These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35733465)
1. A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy. Patel D; Mandal G; Chukwueke L; Woods K Cureus; 2022 May; 14(5):e25165. PubMed ID: 35733465 [TBL] [Abstract][Full Text] [Related]
2. Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination. Kim S; Lee EK; Sohn E J Korean Med Sci; 2023 Feb; 38(8):e57. PubMed ID: 36852853 [TBL] [Abstract][Full Text] [Related]
3. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? Oo WM; Giri P; de Souza A J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365 [TBL] [Abstract][Full Text] [Related]
6. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy]. Radziwill AJ; Kuntzer T; Steck AJ Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589 [TBL] [Abstract][Full Text] [Related]
7. COVID-19-Associated Autoimmune Disease: A Rare First Case Report of Acute Motor Axonal Neuropathy Variant of Guillain-Barre Syndrome in a Woman Patient in New York City. Qureshi Z; Kandhi S; Prasai N; Altaf F; Dhallu M Cureus; 2022 Feb; 14(2):e22290. PubMed ID: 35350485 [TBL] [Abstract][Full Text] [Related]
8. Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report. Smaoui E; Moalla KS; Bouattour N; Farhat N; Sakka S; Daoud S; Damak M; Mhiri C Pan Afr Med J; 2024; 47():46. PubMed ID: 38681104 [TBL] [Abstract][Full Text] [Related]
9. Differentiating recurrent Guillain-Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review. Inan B; Bekircan-Kurt CE; Demirci M; Erdem-Ozdamar S; Tan E Acta Neurol Belg; 2024 Oct; 124(5):1467-1475. PubMed ID: 38664341 [TBL] [Abstract][Full Text] [Related]
10. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy. Chaudhary UJ; Rajabally YA J Neurol; 2021 Apr; 268(4):1366-1373. PubMed ID: 33170339 [TBL] [Abstract][Full Text] [Related]
11. A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man. Patnaik AP; Mininni J; Porter NC; Morris NA Case Rep Neurol; 2021; 13(1):73-77. PubMed ID: 33708097 [TBL] [Abstract][Full Text] [Related]
12. Acute-onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. Fotiadou A; Tsiptsios D; Karatzetzou S; Kitmeridou S; Iliopoulos I Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):116. PubMed ID: 36212671 [TBL] [Abstract][Full Text] [Related]
18. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients. Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827 [TBL] [Abstract][Full Text] [Related]
19. [Respiratory failure can be seen in chronic inflammatory demyelinating polyneuropathy: a case report]. Christani M Lakartidningen; 2022 Feb; 119():. PubMed ID: 35147209 [TBL] [Abstract][Full Text] [Related]